DL-allo-Threonine is a threonine stereochemical variant classified as a proteinogenic, aliphatic amino acid bearing a side-chain hydroxyl group and a β-methyl substituent. The molecule contains both an amino group and a carboxyl group, with the "DL-allo" designation indicating a mixture of stereoisomers at the relevant chiral center(s) relative to allo-threonine, while the side-chain hydroxyl provides hydrogen-bonding and polarity that can influence peptide conformations and solubility. As a free amino acid, it is used as a building block in peptide synthesis and as a substrate or reference material in analytical and structure-property studies that examine how stereochemical variation and side-chain functionality affect incorporation into peptide frameworks.
DL-allo-Threonine is a threonine stereoisomer in which the side-chain hydroxyl-bearing stereocenter is configured as allo, yielding a chiral amino acid with the formula HO-CH(CH3)-CH(NH2)-CO2H in the DL (racemic) form. The molecule contains a primary amino group and a carboxylic acid, enabling salt formation and standard amino acid coupling chemistry, while the β-hydroxyl side chain provides an additional site for derivatization, protection, and selective functional-group transformation. The presence of two stereochemical elements in threonine derivatives makes DL-allo-Threonine a useful stereochemical reference for method development and for studying epimerization, protecting-group behavior, and downstream stereochemical outcomes in peptide-related syntheses. As an amino acid intermediate, DL-allo-Threonine can be converted into protected amino acid derivatives or esters to support peptide building block preparation and subsequent functionalization of the side-chain hydroxyl.
1. Protected Amino Acid Synthesis
DL-allo-Threonine is commonly routed into protected amino acid derivatives for peptide building block preparation and protected amino acid synthesis workflows. The amino and carboxyl functionalities support conversion to N-protected forms and activated C-terminal derivatives, while the side-chain hydroxyl can be protected as an ether or ester to control chemoselectivity during coupling. Racemic DL material can be employed in process chemistry intermediate preparation where stereochemical outcome is monitored through analytical methods or where later resolution is planned. Downstream transformations frequently include deprotection-controlled access to the free amino acid or side-chain hydroxyl for subsequent coupling, derivatization, or scaffold diversification.
2. Peptide Coupling Chemistry
DL-allo-Threonine is suitable for peptide synthesis research and synthetic organic chemistry routes that require incorporation of a threonine stereoisomer into peptide chains. The amino acid backbone participates in standard amide bond formation after conversion to an activated carboxyl derivative, while the β-hydroxyl side chain can be protected to prevent side reactions such as transesterification or undesired acylation. The allo configuration influences steric and stereoelectronic properties at the residue level, which can be relevant for peptide coupling chemistry, protecting-group strategy planning, and stereochemical integrity assessment across synthesis steps. Resulting peptide analogs and intermediate fragments can be used for method comparisons, library construction, and downstream biopolymer modification studies.
3. Side-Chain Functionalization
DL-allo-Threonine supports side-chain functionalization strategies driven by the β-hydroxyl group and the stereochemical context of the allo isomer. The side-chain hydroxyl can be converted into protected alcohol forms for orthogonal synthesis, then selectively transformed into ethers, carbonyl derivatives, or other oxygen-functional motifs that enable further coupling or conjugation chemistry. Racemic material can be used to generate stereochemically mixed intermediate sets for screening of functional-group tolerance in synthetic sequences or for producing reference standards that capture allo-specific reactivity patterns. Generated derivatives can serve as intermediates for peptidomimetics, chemical biology probes, and functionalized amino acid building blocks used in applied product development.
4. Chiral Reference And Resolution Studies
DL-allo-Threonine is applied in chiral synthesis development and analytical research where stereoisomer identity, epimerization behavior, and resolution feasibility require reliable starting material. The racemic DL composition provides a defined stereochemical mixture that can be used to investigate how protecting groups and coupling conditions affect allo versus other threonine stereoisomers during protected amino acid chemistry. The chiral center arrangement can be monitored by chiral chromatography, derivatization-based NMR methods, or conversion to diastereomeric derivatives for stereochemical assignment. Downstream use includes preparation of resolved enantiomers after chiral separation steps, as well as generation of stereochemical standards for method validation in amino acid and peptide analysis.
5. Bioconjugation Building Blocks
DL-allo-Threonine can be employed as an amino acid-based intermediate for bioconjugation chemistry where side-chain hydroxyl functionality is leveraged for controlled derivatization. The amino acid core enables attachment to linker scaffolds through amide formation after activation or through orthogonal protection/deprotection sequences that expose the reactive hydroxyl when needed. Allo stereochemistry can influence linker geometry and local conformational preferences in conjugates, making the stereoisomer relevant for constructing peptide-tagged or amino acid-derived conjugation reagents used in chemical biology workflows. Produced conjugation-ready derivatives can feed into downstream biomolecule labeling, immobilized reagent preparation, and analytical tracer generation for studying binding interactions and reaction compatibility.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More